AMS arises from an inappropriate response to hypoxic conditions, characterized predominantly by persistent headaches and often accompanied by non-specific symptoms like nausea, vomiting, general fatigue, loss of appetite, and sleep disturbances (Hackett et al., 1976)
Because menopause already alters your metabolism and fat distribution, stopping a GLP-1 medication introduces specific risks your team will need to manage: Hormonal hunger: When a GLP-1 medication leaves your system, its appetite suppressing effects wear off
TRANSFORM Sugar Transforming Enzymes GLOW COLLAGEN Advanced Type 1 Collagen with Superfood Antioxidant Support CLEAR PROTEIN DRINK 20 Grams of Clear Whey Isolate Protein
They have broadened our understanding of the molecular functions of IGF-1R in different disease stages and highlight the potential of IGF-1R targeting in patients with BrCa
When you're eating significantly less, especially if protein intake drops, your body doesn't just burn stored fat for energy